Unión Europea - español - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacunas - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cz vaccines s.a.u. - brucella abortus, viva atenuada (fase lisa), cepa b-19 - polvo y disolvente para colirio en suspensiÓn - brucella abortus, viva atenuada (fase lisa), cepa b-19 4ufc - vacunas bacterianas vivas - bovino

Unión Europea - español - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Unión Europea - español - EMA (European Medicines Agency)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vacunas - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

Unión Europea - español - EMA (European Medicines Agency)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vacunas - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

medochemie limited - dexketoprofeno trometamol - comprimido recubierto con pelÍcula - 12,5 mg - dexketoprofeno trometamol 12,5 mg - dexketoprofeno

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - fentanilo - parche transdÉrmico - 12 microgramos/h - fentanilo 12 microgramos/h - fentanilo

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

lavipharm s.a. - fentanilo - parche transdÉrmico - 12 microgramos/h - fentanilo 12 microgramos/h - fentanilo

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorio stada s.l. - fentanilo - parche transdÉrmico - 12 microgramos/h - fentanilo 12 microgramos/h - fentanilo

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aristo pharma iberia s.l. - fentanilo - parche transdÉrmico - 12 microgramos/h - fentanilo 12 microgramos/h - fentanilo